To healthcare providers and patients:

In response to the spread of the COVID-19 virus, IBSA would like to reassure you about the safety and availability of our products. Both Tirosint and Tirosint-SOL are:

  • Made in our state-of-the-art production facility in Switzerland. No ingredients are sourced from Asian suppliers
  • Currently in stock and available. No shortages or interruption of supply are anticipated
  • Available in retail pharmacies and via Tirosint Direct, a convenient direct mail pharmacy service that delivers your prescription to your home within 2-3 days after your order has been processed. The Tirosint Direct Program stocks all doses of Tirosint and Tirosint-SOL and offers the lowest out-of-pocket cost for patients regardless of their insurance coverage. For more information about Tirosint Direct, please visit https://www.tirosint.com/patient-savings-resources/tirosint-direct-program/ or https://tirosintsol.com/tirosint-direct-program/

Healthcare professionals can contact IBSA’s Medical Information line for customer service, patient assistance information, product information and adverse event reporting. Please call 1-800-587-3513.

Healthcare professionals can contact their local IBSA sales representative for samples and patient support materials.